Physician profile
Marci Malone
NPI 1487638029
$1,671.64
in general payments reported to CMS, 2019-2025
20 companies · $424 in 2025
The $424 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $359 · 2021: $217 · 2022: $33.29 · 2023: $348 · 2024: $184 · 2025: $424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $956.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $374.94 | 2019-2025 | Xifaxan |
| Ironwood Pharmaceuticals, INC | $224.42 | 2020 | |
| Ardelyx, INC. | $216.58 | 2023-2025 | Ibsrela |
| Janssen Biotech, INC. | $183.55 | 2020-2025 | Tremfya, Simponi, Stelara |
| Halozyme INC | $169.07 | 2021-2025 | Hylenex Recombinant |
| Braintree Laboratories, INC. | $79.00 | 2019-2020 | |
| Redhill Biopharma INC. | $69.62 | 2021 | |
| Qol Medical, LLC | $63.70 | 2025 | Sucraid |
| Aimmune Therapeutics, INC. | $49.96 | 2025 | Zenpep |
| Intercept Pharmaceuticals, INC. | $41.72 | 2024-2025 | |
| Rayner Intraocular Lenses Limited | $27.20 | 2025 | Omidria |
| Evoke Pharma, INC. | $24.83 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $23.95 | 2024 | Kristalose |
| Merck Sharp & Dohme LLC | $20.72 | 2021 | |
| Valinor Pharma, LLC | $20.09 | 2023 | Movantik |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $19.67 | 2023 | Qsymia |
| Endo Pharmaceuticals INC. | $17.54 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.19 | 2021 | |
| Enterra Medical, INC. | $15.66 | 2024 | |
| Eyepoint US, INC. | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marci Malone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.